Tango Therapeutics' (TNGX) Sees Cautious Analyst Optimism Following Earnings [Yahoo! Finance]
Tango Therapeutics, Inc. (TNGX)
Company Research
Source: Yahoo! Finance
Tango Therapeutics Inc. (NASDAQ:TNGX) is one of the 11 Best Day Trading Stocks to Buy Now Financial firm Mizuho raised its share price target for Tango Therapeutics Inc. (NASDAQ:TNGX) on March 11th. It slightly adjusted the target to $20 from $19 and kept an Outperform rating on the stock. Mizuho's coverage came after the precision oncology company reported its earnings for the fourth quarter and full year 2025. The results saw Tango Therapeutics Inc. (NASDAQ:TNGX) post $343 million in cash and outline that it expected to have runway beyond 2028. The firm also outlined that it was on track to start a study for pancreatic cancer treatment and added that it had entered into an agreement for evaluating a molecular glue in a clinical trial. Tango Therapeutics' (TNGX) Sees Cautious Analyst Optimism Following Earnings Wedbush also discussed Tango Therapeutics Inc. (NASDAQ:TNGX)'s shares in March. It raised the share price target to $19 from $15 and kept an Outperform rating on the st
Show less
Read more
Impact Snapshot
Event Time:
TNGX
Last Price
Price Change
Price Change%
Volume Shares
Max Up
Max Down
%
Volume Ratio
Performance Comparison
Updated
|
Event Day
Stock performance from the time of news release until the following 4pm ET market close
|
Last price at news event
|
Since Event
Multi-day stock performance from the time of the news release
|
|---|---|---|
|
EVENT DAY
Stock performance from the time of news release until the following 4pm ET market close
|
LAST
PRICE AT NEWS EVENT |
SINCE EVENT
Multi-day stock performance from the time of the news release
|
| Last Price | ||
| VWAP | ||
|
High:
|
Max Up |
High:
|
|
Low:
|
Max Down |
Low:
|
|
%
|
Post news range |
%
|
|
|
Price change |
|
|
|
Price Change Percentage |
|
|
|
S&P 500 (SPX) |
|
|
%
|
Volume ratio |
%
|
| Volume | ||
| Ticks | ||
|
|
Avg transaction size |
|
Don't Miss Out On The Next BIG Stock Move
Event day
Event Day Chart will not be displayed beyond 90-day period of the event
Performance since event
Time And Velocity Analysis
Be the first to know
Opt in for alerts from News Quantifed
Sign Up Today
Opt-in for
TNGX alerts
Learn More With NQ
Reading the Impact Report
Help Me Understand This Data
Help Me Understand This Data
How NQ Works
What is news-based trading?
And why is it so successful?
And why is it so successful?
Movers & Shakers
The biggest gainers and losers and WHY it moved
TNGX alerts
High impacting Tango Therapeutics, Inc. news events
Weekly update
A roundup of the hottest topics
TNGX
News
- Tango Therapeutics (TNGX) was downgraded by <a style="font-weight:bold" href="https://www.wallstreetzen.com/newsletters/zen-ratings?ticker=TNGX&utm_campaign=getratings&utm_medium=online&utm_source=MarketBeat">Wall Street Zen</a> from "holMarketBeat
- Wedbush Reaffirms Outperform Rating for Tango Therapeutics (TNGX) [Yahoo! Finance]Yahoo! Finance
- Tango Therapeutics (TNGX) had its price target raised by Mizuho from $19.00 to $20.00. They now have an "outperform" rating on the stock.MarketBeat
- Tango Therapeutics (TNGX) had its price target raised by Stifel Nicolaus from $15.00 to $24.00. They now have a "buy" rating on the stock.MarketBeat
- Tango Therapeutics (TNGX) Soars 52% on Buy Reco [Yahoo! Finance]Yahoo! Finance
TNGX
Earnings
- 3/5/26 - Beat
TNGX
Sec Filings
- 3/9/26 - Form 4
- 3/5/26 - Form 144
- 3/5/26 - Form S-8
- TNGX's page on the SEC website